Skip to Content

Dymista Approval History

FDA Approved: Yes (First approved May 1, 2012)
Brand name: Dymista
Generic name: azelastine and fluticasone
Dosage form: Nasal Spray
Company: Meda Pharmaceuticals, Inc.
Treatment for: Allergic Rhinitis

Dymista (azelastine and fluticasone) nasal spray is an H1-receptor antagonist and corticosteroid combination indicated for the relief of symptoms of seasonal allergic rhinitis.

Development History and FDA Approval Process for Dymista

May  2, 2012Approval MEDA Announces Dymista Approved by the FDA

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.